High-purity lyophilized peptides for in vitro research. All compounds verified ≥99% purity by HPLC. Shipped discreetly across Canada.
14 peptides
GLP-1 / GIP / Glucagon Triple Agonist
Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. It represents one of the most potent investigational compounds for metabolic research, demonstrating significant effects on body weight and glucose regulation in preclinical and early clinical studies.
GLP-1 / GIP Dual Agonist
Tirzepatide is a dual GLP-1 and GIP receptor agonist that has been extensively studied for its effects on metabolic function, body composition, and glycemic control. It is one of the most researched peptides in the GLP-1 class.
GHRH Analogue
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to produce and release growth hormone in a physiologically pulsatile manner. Research has focused on its effects on visceral adipose tissue and body composition.
Mitochondrial Peptide
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide encoded within the mitochondrial genome. It plays a key role in metabolic homeostasis, insulin sensitivity, and cellular energy regulation.
Copper Peptide
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It has been extensively studied for its roles in wound healing, collagen synthesis, anti-inflammatory activity, and gene expression regulation.
BPC-157 + GHK-Cu + TB-500 Blend
GLOW is a proprietary research blend combining BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg). Each component has been individually studied for tissue repair, regeneration, and anti-inflammatory properties. The combination is designed to explore synergistic effects on recovery and cellular health.
GHK-Cu + TB-500 + BPC-157 + KPV Blend
KLOW is an advanced research blend combining GHK-Cu (50mg), TB-500 (10mg), BPC-157 (10mg), and KPV (10mg). KPV is a tripeptide derived from alpha-MSH with notable anti-inflammatory properties, making this blend of interest for comprehensive tissue and immune research.
Melanocortin Peptide
Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH). It acts on melanocortin receptors and has been studied for its effects on pigmentation, energy homeostasis, and other melanocortin-mediated processes.
Master Antioxidant Tripeptide
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine. It is the most abundant intracellular antioxidant in mammalian cells and plays a central role in oxidative stress defense, detoxification, and immune function.
Nootropic + Anxiolytic Neuropeptide Blend
A dual-neuropeptide research blend combining Semax (10mg) and Selank (10mg). Semax is a synthetic ACTH-derived heptapeptide studied for BDNF upregulation and cognitive enhancement. Selank is a tuftsin analogue researched for anxiolytic and GABAergic modulation. Together they offer a complementary nootropic and stress-resilience profile for neuroscience research.
Nicotinamide Adenine Dinucleotide
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells, essential for energy metabolism, DNA repair, and cellular signaling. Research into NAD+ has expanded significantly due to its role in aging biology and mitochondrial function.
GHRH / GHRP Blend
This research blend combines Ipamorelin (a selective GHRP) and CJC-1295 (a GHRH analogue) to study synergistic effects on growth hormone secretion. The combination targets both GHRH receptors and ghrelin receptors to maximize pulsatile GH release.
Melanocortin Agonist
PT-141 (Bremelanotide) is a synthetic melanocortin peptide derived from Melanotan II. Unlike other compounds in this class, PT-141 acts centrally on the nervous system via melanocortin receptors. It has been studied for its effects on sexual function and arousal pathways.
Neuropeptide / GPR54 Agonist
Kisspeptin is a neuropeptide encoded by the KISS1 gene and acts as the primary regulator of the hypothalamic-pituitary-gonadal (HPG) axis. It is a critical upstream regulator of GnRH secretion and has been extensively studied in reproductive endocrinology research.